sglt2 inhibitors and glp 1 receptor agonists Cardiorenal Protection: Potential of GLP-1 in the Treatment of Type 2 Diabetes | Diabetes Therapy Little is known about the

"It starts with heightened surveillance from both the patient and the physician," Dr

How have Medicaid prescriptions and gross spending on GLP-1s changed in recent years

W.GreigN

To date, there have been no reports of pharmacokinetic DDIs involving metabolic enzymes or transporters

These medications mimic the effects of the bodys natural GLP-1 hormone, helping regulate blood sugar, curb appetite, and slow digestion a combination that supports both metabolic health and fat loss

Dosing Comparison# Retatrutide Dosing# Based on Phase 2 trial data: Route : Once-weekly subcutaneous injection Dose range studied : 0.5 mg to 12 mg weekly Optimal dose : 12 mg weekly showed maximum efficacy in Phase 2 Titration : Gradual dose escalation over several weeks to manage GI tolerability Tirzepatide Dosing# Established FDA-approved dosing: Route : Once-weekly subcutaneous injection Starting dose : 2.5 mg weekly for 4 weeks Maintenance range : 5 mg, 10 mg, or 15 mg weekly Titration : 2.5 mg increments every 4 weeks to target dose Available formulations : Prefilled pens (Mounjaro/Zepbound) Tirzepatide's established titration protocol and prefilled pen delivery system offer practical advantages in clinical use